Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › FcRn-targeted therapeutics for the treatment of antibody-mediated autoimmune and albumin-mediated disease

FcRn-targeted therapeutics for the treatment of antibody-mediated autoimmune and albumin-mediated disease

US Patent 11471526 · Granted Oct 18, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Data transmission method, processor system, and memory access system2025
Electrical plug2025
Method and apparatus for controlling internal memory bandwidth, processor, and c2025
Compositions and methods for mucosal vaccination against SARS-CoV-22025
FcRn-targeted mucosal vaccination against influenza infections2025
Method for driving light-emitting substrate with light-emitting sub-regions, dri2025
Method for driving pixel array, device, and display panel2025
FcRn-targeted mucosal vaccination against RSV2024
FcRn-targeted therapeutics for the treatment of antibody-mediated autoimmune and2024
FcRn-targeted therapeutics for the treatment of antibody-mediated autoimmune and2024
Stacked-screen display device and method for controlling display device2024
Method and device for network traffic scheduling2024